Products

At CuraMedix, innovation knows no boundaries. The commitment to the innovation and advancement of leading non-invasive technologies such as Extracorporeal Pulse Activation Technology (EPAT®) that offer multi-therapeutic solutions keep CuraMedix focused on its core mission - to provide medical professionals the best products and most advanced treatment solutions to treat patients more effectively and efficiently. With a focus on superior patient outcomes, CuraMedix is tirelessly working to expand current product offerings as well as developing new, ground-breaking technologies.

Through better products, simplified surgical alternatives and efficiencies, we are helping medical professionals treat patients more effectively and patients return to their normal lives faster and reduce health-care costs.

D-Actor 200
D-Actor 200® - The First High Frequency Pain Management System

The D-Actor® 200 with EPAT® (Extracorporeal Pulse Activation Technology) the First High Frequency pain management system with a broad range of applications make the D-Actor 200 system the most advanced and versatile non-invasive, in-office treatment solution.

The highlights of this High-Frequency Pain Management System include: broad range of non-invasive applications, no anesthetics required, shortened recovery, excellent results, short treatment sessions, safe application, low capital expenditure and maintenance costs, ergonomic compact design for maximum mobility.

Duolith SD1
Duolith SD1®

The First Extracorporeal Pulse Activation Treatment System that combines several proprietary technologies including our High-Energy focused Cylindrical- Source Electromagnetic (F-SW) Technology with our versatile and efficient High Frequency Radial (R-PW) Technology and optional Planar (P-SW) Technology to create the most advanced Non-Invasive Treatment System second to none. Modern physics, state-of-the-art technology, dynamic energy range and designed for maximum ease of use.

The Duolith SD1® is CE marked for international markets however, is not currently FDA approved for sale or distribution in the United States.